Generex (GNBT +28%) is up strongly after the FDA said earlier this morning it will allow...

|About: Generex Biotechnology C... (GNBT)|By:, SA News Editor

Generex (GNBT +28%) is up strongly after the FDA said earlier this morning it will allow patients with serious or life-threatening diabetes to use its yet-unapproved orally-administered insulin product Oral-lyn. (PR)